News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,939 Results
Type
Article (47256)
Company Profile (365)
Press Release (687318)
Multimedia
Podcasts (97)
Webinars (12)
Section
Business (213604)
Career Advice (2157)
Deals (37136)
Drug Delivery (115)
Drug Development (84268)
Employer Resources (176)
FDA (16786)
Job Trends (15773)
News (361576)
Policy (34706)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (14)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (7)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2708)
Accelerated approval (5)
Adcomms (21)
Allergies (91)
Alliances (52330)
ALS (94)
Alzheimer's disease (1416)
Antibody-drug conjugate (ADC) (145)
Approvals (16787)
Artificial intelligence (272)
Autoimmune disease (25)
Automation (16)
Bankruptcy (380)
Best Places to Work (11957)
BIOSECURE Act (20)
Biosimilars (116)
Biotechnology (239)
Bladder cancer (77)
Brain cancer (29)
Breast cancer (289)
Cancer (2313)
Cardiovascular disease (188)
Career advice (1806)
Career pathing (31)
CAR-T (157)
Cell therapy (439)
Cervical cancer (19)
Clinical research (68340)
Collaboration (863)
Compensation (529)
Complete response letters (25)
COVID-19 (2728)
CRISPR (45)
C-suite (252)
Cystic fibrosis (103)
Data (2212)
Decentralized trials (2)
Denatured (33)
Depression (45)
Diabetes (276)
Diagnostics (6558)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (125)
Drug pricing (117)
Drug shortages (28)
Duchenne muscular dystrophy (95)
Earnings (88905)
Editorial (40)
Employer branding (22)
Employer resources (150)
Events (118274)
Executive appointments (742)
FDA (18054)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (775)
Gene editing (112)
Generative AI (22)
Gene therapy (325)
GLP-1 (770)
Government (4634)
Grass and pollen (5)
Guidances (54)
Healthcare (19455)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (134)
Indications (30)
Infectious disease (2875)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (98)
Interviews (334)
IPO (16919)
IRA (48)
Job creations (4242)
Job search strategy (1541)
Kidney cancer (10)
Labor market (38)
Layoffs (509)
Leadership (17)
Legal (8708)
Liver cancer (78)
Lung cancer (330)
Lymphoma (154)
Machine learning (7)
Management (59)
Manufacturing (323)
MASH (69)
Medical device (13762)
Medtech (13767)
Mergers & acquisitions (20752)
Metabolic disorders (720)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (95)
Neuropsychiatric disorders (29)
Neuroscience (1976)
NextGen: Class of 2025 (6883)
Non-profit (4655)
Northern California (2704)
Now hiring (40)
Obesity (387)
Opinion (240)
Ovarian cancer (76)
Pain (94)
Pancreatic cancer (84)
Parkinson's disease (151)
Partnered (21)
Patents (240)
Patient recruitment (109)
Peanut (50)
People (60295)
Pharmaceutical (96)
Pharmacy benefit managers (19)
Phase I (21216)
Phase II (30041)
Phase III (22517)
Pipeline (1195)
Policy (154)
Postmarket research (2747)
Preclinical (9118)
Press Release (69)
Prostate cancer (108)
Psychedelics (33)
Radiopharmaceuticals (254)
Rare diseases (404)
Real estate (6519)
Recruiting (68)
Regulatory (23527)
Reports (46)
Research institute (2441)
Resumes & cover letters (364)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (76)
Series A (138)
Series B (88)
Service/supplier (14)
Sickle cell disease (58)
Southern California (2345)
Special edition (15)
Spinal muscular atrophy (151)
Sponsored (31)
Startups (3831)
State (2)
Stomach cancer (15)
Supply chain (70)
Tariffs (42)
The Weekly (62)
United States (23456)
Vaccines (720)
Venture capitalists (43)
Weight loss (262)
Women's health (37)
Worklife (15)
Date
Today (212)
Last 7 days (916)
Last 30 days (2767)
Last 365 days (33788)
2025 (10754)
2024 (36247)
2023 (41076)
2022 (52249)
2021 (56829)
2020 (55452)
2019 (48286)
2018 (36572)
2017 (33713)
2016 (33479)
2015 (39508)
2014 (33456)
2013 (28639)
2012 (30785)
2011 (31368)
2010 (29521)
Location
Africa (896)
Alabama (59)
Alaska (7)
Arizona (245)
Arkansas (14)
Asia (41852)
Australia (6765)
California (6266)
Canada (2020)
China (538)
Colorado (271)
Connecticut (275)
Delaware (149)
Europe (89202)
Florida (906)
Georgia (204)
Idaho (57)
Illinois (550)
India (26)
Indiana (315)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4634)
Michigan (223)
Minnesota (396)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1735)
New Mexico (29)
New York (1747)
North Carolina (1014)
North Dakota (8)
Northern California (2704)
Ohio (203)
Oklahoma (14)
Oregon (40)
Pennsylvania (1381)
Puerto Rico (13)
Rhode Island (33)
South America (1244)
South Carolina (23)
South Dakota (1)
Southern California (2345)
Tennessee (102)
Texas (914)
Utah (183)
Virginia (154)
Washington D.C. (63)
Washington State (562)
West Virginia (3)
Wisconsin (57)
734,939 Results for "millennium pharmaceuticals inc south san francisco california".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DotBio joins JLABS South San Francisco
DotBio has been accepted into Johnson & Johnson’s global incubator network, JLABS South San Francisco.
March 21, 2025
·
1 min read
Press Releases
SIFI announces collaboration with the University of California, San Francisco on Acanthamoeba Keratitis
March 19, 2025
·
5 min read
Press Releases
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
March 4, 2025
·
2 min read
Press Releases
Rivus Pharmaceuticals Expands Leadership Team and Establishes New San Francisco Bay Area Office Ahead of Phase 2 Read-Out in MASH
April 10, 2025
·
7 min read
Biotech Bay
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA.
May 8, 2024
·
3 min read
Press Releases
University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
January 15, 2025
·
5 min read
Press Releases
Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
December 20, 2024
·
4 min read
Biotech Bay
Nutcracker Therapeutics’ Research Partner, the University of California, San Francisco, Presents Foundational Prostate Cancer Data at AAI 2024
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, detailed data presented by its partners at the University of California, San Francisco on foundational prostate cancer antigen research utilized to inform the development of its mRNA drug candidate, NTX-470.
May 15, 2024
·
4 min read
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
Dyadic International, Inc. today announced that Joseph Hazelton, Chief Business Officer and Doug Pace, Executive Vice President of Business Development will be attending the Future Food-Tech “Innovation & Investment from Farm to Fork” event March 21 – 22, 2024 at the San Francisco Marriott Marquis in California.
March 21, 2024
·
5 min read
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
1 of 73,494
Next
